Header Logo

Connection

SUMIT K. SUBUDHI to Androstenes

Back to Details
This is a "connection" page, showing publications SUMIT K. SUBUDHI has written about Androstenes.
SUMIT K. SUBUDHI
Connection Strength
0.047
Androstenes
  1. A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2021 02; 19(1):22-31.e5.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.